Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity

Free Radical Biology and Medicine

Volumn 23, Issue 5, 1997, Pages 775-782

  Gille, Lars ^a   Nohl, Hans ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Adriamycin; Adriamycin aglycone; Exogenous NADH dehydrogenase; Free radicals; Heart mitochondria; Liver mitochondria; Oxygen radicals; Semiquinones

Indexed keywords

ADRIAMYCINONE; ANTHRAQUINONE; DOXORUBICIN; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON SPIN RESONANCE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; HYDROXYL RADICAL; KINETICS; MALE; MITOCHONDRIA, HEART; MITOCHONDRIA, LIVER; NADH DEHYDROGENASE; NAPHTHACENES; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

ANIMALIA;

EID: 0030804864     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00025-7     Document Type: Article

References (27)

1. Carter S. K. Adriamycin, a review. J. Natl. Cancer Inst. 55:1975;1256-1274.
2. Sokolove P. M. Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity. Int. J. Biochem. 26:1994;1341-1350.
3. Monti E., Piccinini F., Villani F., Favalli L. Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat. Cancer Chemother. Pharmacol. 18:1986;289-291.
4. 2; An explanation for the cardiotoxicity of anthracycline antibiotics. Biochem. Biophys. Res. Commun. 114:1983;197-205.
5. Sokolove P. M., Kester M. B., Haynes J. Interaction of adriamycin aglycones with isolated mitochondria. Effect of selenium deficiency. Biochem. Pharmacol. 46:1993;691-697.
6. Doroshow J. H., Davies K. J. A. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261:1986;3068-3074.
7. Davies K. J. A., Doroshow J. H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261:1986;3060-3067.
8. Matsumura M., Nishioka K., Fujii T., Yoshibayashi M., Nozaki K., Nakata Y., Temma S., Ueda T., Mikawa H. Age-related acute adriamycin cardiotoxicity in mice. J. Mol. Cell Cardiol. 26:1994;899-905.
9. Demant E. J. F. Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin. Biochem. Pharmacol. 41:1991;543-552.
10. Nohl H. Identification of the site of adriamycin-activation in the heart cell. Biochem. Pharmacol. 37:1988;2633-2637.
11. Iwamoto Y., Hansen I. L., Porter T. H., Folkers K. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase by adriamycin and other quinones having antitumor activity. Biochem. Biophys. Res. Commun. 58:1974;633-638.
12. Nohl H. Demonstration of the existence of an organo-specific NADH dehydrogenase in heart mitochondria. Eur. J. Biochem. 169:1987;585-591.
13. Rasmussen U. F., Rasmussen H. N. The NADH oxidase system (external) of muscle mitochondria and its role in the oxidation of cytoplasmic NADH. Biochem. J. 229:1985;631-641.
14. Schönheit K., Nohl H. Oxidation of cytosolic NADH via complex I of heart mitochondria. Arch. Biochem. Biophys. 327:1996;319-323.
15. Lin Tj., Liu Gt., Pan Y., Liu Y., Xu G. Z. Protection by schisanhenol against adriamycin toxicity in rat heart mitochondria. Biochem. Pharmacol. 9:1991;1805-1810.
16. Afanasev I. B., Polozova N. I. Kinetics and mechanism of the reactions of superoxide ion in solution. Part 6. Interaction of superoxide ion with adriamycin in aprotic and protic media. J. Chem. Soc. Perkin Trans. II:1987;835-839.
17. Komiyama T., Kikuchi T., Sugiura Y. Interaction of anticancer quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and oxygen. J. Pharmacobiodyn. 9:1986;651-664.
18. Gewirtz D. A., Yanovich S. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit. Biochem. Pharmacol. 35:1986;4059-4064.
19. Szarkowska L., Klingenberg M. On the role of ubisemiquinone in mitochondria. Biochem. Zeitschrift. 338:1963;674-697.
20. Takanashi S., Bachur N. R. Doxorubicin metabolites in human urine. J. Pharmacol. Exp. Ther. 195:1975;41-49.
21. Bachur N. R., Cradock J. C. Daunomycin metabolism in rat tissue slices. J. Pharmacol. Exp. Ther. 175:1970;331-337.
22. Buettner G. R. Spin trapping: ESR parameters of spin adducts. Free Radic. Biol. Med. 3:1987;259-303.
23. Schönheit K., Gille L., Nohl H. Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria. Biochim. Biophys. Acta. 1271:1995;335-342.
24. Lea J. S., Rushton F. A. P., Land E. J., Swallow A. J. The reductive deglycosylation of adriamycin in aqueous medium: A pulse radiolysis study. Free Radic. Res. Commun. 8:1990;241-249.
25. Nohl H., Stolze K. Ubisemiquinones of the mitochondrial respiratory chain do not interact with molecular oxygen. Free Radic. Res. Commun. 16:1992;409-419.
26. Nohl H., Gille L., Schönheit K., Liu Y. Conditions allowing redox-cycling ubisemiquinone in mitochondria to establish a direct redox couple with molecular oxygen. Free Radic. Biol. Med. 20:1996;207-213.
27. Ji L. L., Mitchell E. W. Effects of adriamycin on heart mitochondrial function in rested and exercised rats. Biochem. Pharmacol. 47:1994;877-885.